Global Non-ionic Monomeric Contrast Medium Market Growth 2023-2029
The global Non-ionic Monomeric Contrast Medium market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Non-ionic Monomeric Contrast Medium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-ionic Monomeric Contrast Medium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-ionic Monomeric Contrast Medium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-ionic Monomeric Contrast Medium players cover GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma and Daiichi Sankyo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Non-ionic Monomeric Contrast Medium Industry Forecast” looks at past sales and reviews total world Non-ionic Monomeric Contrast Medium sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-ionic Monomeric Contrast Medium sales for 2023 through 2029. With Non-ionic Monomeric Contrast Medium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-ionic Monomeric Contrast Medium industry.
This Insight Report provides a comprehensive analysis of the global Non-ionic Monomeric Contrast Medium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-ionic Monomeric Contrast Medium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Non-ionic Monomeric Contrast Medium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-ionic Monomeric Contrast Medium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-ionic Monomeric Contrast Medium.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-ionic Monomeric Contrast Medium market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
X-ray and CT Contrast Medium
MRI Contrast Medium
Ultrasound Contrast Medium
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Daiichi Sankyo
Takeda
Grupo Juste
Fuji Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-ionic Monomeric Contrast Medium market?
What factors are driving Non-ionic Monomeric Contrast Medium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-ionic Monomeric Contrast Medium market opportunities vary by end market size?
How does Non-ionic Monomeric Contrast Medium break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.